The Food and Drug Administration approves a new drug to protect babies and children from respiratory syncytial virus

US officials on Monday approved the first long-acting drug to protect infants and young children from the respiratory virus that sends tens of thousands of American children to the hospital each year. RSV is a cold-like nuisance for most healthy people, but it can be life-threatening to the very young and very old. The Food … Read more